TY - JOUR
T1 - Adult cases of late-onset congenital central hypoventilation syndrome and paired-like homeobox 2B-mutation carriers
T2 - an additional case report and pooled analysis
AU - Hino, Aoi
AU - Terada, Jiro
AU - Kasai, Hajime
AU - Shojima, Hikaru
AU - Ohgino, Keiko
AU - Sasaki, Ayako
AU - Hayasaka, Kiyoshi
AU - Tatsumi, Koichiro
N1 - Funding Information:
The authors thank Sinobu Ikeda in Chiba University Hospital and medical staffs in Kawasaki Municipal Hospital for the technical support, analysis of polysomnography, and the clinical information. We also thank the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, especially the Alveolar Hypoventilation Research group in the Ministry of Health, Labour and Welfare Japan for their dedicated scientific support. Author Contributions: A.H., H.S., H.K., K.O., A.S., K.H., and J.T. performed data collection and analyzed the data, and A.H., J.T., A.S., K.H., and K.T. contributed to the writing of the manuscript. J.T. and K.T. planned and designed the study.
Funding Information:
All authors have seen and approved this manuscript. Work for this study was performed at Chiba University Hospital. This study was partly supported by the Japanese Ministry of Health, Labour and Welfare research grants specifically designated to the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group.
Publisher Copyright:
Copyright © 2020 American Academy of Sleep Medicine. All rights reserved.
PY - 2020/11/15
Y1 - 2020/11/15
N2 - Study Objectives: Congenital central hypoventilation syndrome (CCHS) is caused by the paired-like homeobox 2B (PHOX2B) mutation and predominantly diagnosed during the neonatal period. Although late-onset CCHS and PHOX2B mutation carriers have been reported, the features of these disease states in adults remain uncertain. This study aimed to identify the characteristics of adult-onset CCHS and PHOX2B-mutation carriers in adult. Methods: We mainly searched the PubMed/Medline and Cochrane Databases and classified our target patients into 2 groups: group A, symptomatically diagnosed with late-onset CCHS in adulthood; group B, adult PHOX2B-mutation carriers. Then, clinical characteristics, including the onset, treatment, long-term course, and pattern of the PHOX2B mutation in both groups were analyzed. Additionally, a new adult-case of late-onset CCHS was added to the analysis. Results: Group A was comprised of 12 patients. The onset triggers of illness included a history of respiratory compromise following general anesthesia and respiratory tract infections. All patients in group A had 20/25 polyalanine repeat mutations and required some chronic ventilatory support at least during sleep, including portable positive pressure ventilator via tracheostomy or noninvasive positive pressure ventilation. In these patients with ventilatory support during sleep, sudden death or poor prognosis was not reported. Group B was comprised of 33 adults from 24 families with PHOX2B mutations. Nine patients in group B were confirmed with the diagnosis of CCHS. Although polyalanine repeat mutations 20/25 represented the most common gene mutation, diverse mutations, including mosaicism, were observed. Hypoventilation of several cases in group B were underdiagnosed by overnight polysomnography without monitoring for CO2. Conclusion: Alveolar hypoventilation with unknown origin can be caused by the PHOX2B mutation even in adult cases. Both the identification of the PHOX2B mutation and the incorporation of capnography in polysomnography are important for adult cases with unexplained alveolar hypoventilation or asymptomatic mutation carriers.
AB - Study Objectives: Congenital central hypoventilation syndrome (CCHS) is caused by the paired-like homeobox 2B (PHOX2B) mutation and predominantly diagnosed during the neonatal period. Although late-onset CCHS and PHOX2B mutation carriers have been reported, the features of these disease states in adults remain uncertain. This study aimed to identify the characteristics of adult-onset CCHS and PHOX2B-mutation carriers in adult. Methods: We mainly searched the PubMed/Medline and Cochrane Databases and classified our target patients into 2 groups: group A, symptomatically diagnosed with late-onset CCHS in adulthood; group B, adult PHOX2B-mutation carriers. Then, clinical characteristics, including the onset, treatment, long-term course, and pattern of the PHOX2B mutation in both groups were analyzed. Additionally, a new adult-case of late-onset CCHS was added to the analysis. Results: Group A was comprised of 12 patients. The onset triggers of illness included a history of respiratory compromise following general anesthesia and respiratory tract infections. All patients in group A had 20/25 polyalanine repeat mutations and required some chronic ventilatory support at least during sleep, including portable positive pressure ventilator via tracheostomy or noninvasive positive pressure ventilation. In these patients with ventilatory support during sleep, sudden death or poor prognosis was not reported. Group B was comprised of 33 adults from 24 families with PHOX2B mutations. Nine patients in group B were confirmed with the diagnosis of CCHS. Although polyalanine repeat mutations 20/25 represented the most common gene mutation, diverse mutations, including mosaicism, were observed. Hypoventilation of several cases in group B were underdiagnosed by overnight polysomnography without monitoring for CO2. Conclusion: Alveolar hypoventilation with unknown origin can be caused by the PHOX2B mutation even in adult cases. Both the identification of the PHOX2B mutation and the incorporation of capnography in polysomnography are important for adult cases with unexplained alveolar hypoventilation or asymptomatic mutation carriers.
KW - CCHS
KW - Congenital central hypoventilation syndrome
KW - Late-onset CCHS
KW - PHOX2B
KW - Polysomnography
KW - Transcutaneous carbon dioxide monitoring
UR - http://www.scopus.com/inward/record.url?scp=85096347758&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096347758&partnerID=8YFLogxK
U2 - 10.5664/jcsm.8732
DO - 10.5664/jcsm.8732
M3 - Article
C2 - 32741443
AN - SCOPUS:85096347758
SN - 1550-9389
VL - 16
SP - 1891
EP - 1900
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 11
ER -